Opko Health, Inc. OPK
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -60.01% | 31.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -60.01% | 31.71% | |||
| Cost of Revenue | -78.45% | 8.44% | |||
| Gross Profit | -14.06% | 182.99% | |||
| SG&A Expenses | -53.07% | 8.88% | |||
| Depreciation & Amortization | -13.24% | 0.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -48.67% | 7.65% | |||
| Operating Income | -25.43% | 50.91% | |||
| Income Before Tax | -219.92% | 78.02% | |||
| Income Tax Expenses | -46.70% | 18.45% | |||
| Earnings from Continuing Operations | -322.48% | 84.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -536.10% | 84.66% | |||
| EBIT | -25.43% | 50.91% | |||
| EBITDA | -229.61% | 90.86% | |||
| EPS Basic | -545.95% | 84.65% | |||
| Normalized Basic EPS | -38.08% | 44.92% | |||
| EPS Diluted | -567.57% | 84.65% | |||
| Normalized Diluted EPS | -38.08% | 44.92% | |||
| Average Basic Shares Outstanding | -1.16% | -0.48% | |||
| Average Diluted Shares Outstanding | -1.16% | -0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||